SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950134-07-003566
Filing Date
2007-02-16
Accepted
2007-02-16 16:30:05
Documents
2
Group Members
JOHN S CLARK IIROBERT W BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP LLCSOUTHPOINT GP LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d43593asc13g.htm SC 13G 112930
2 JOINT FILING AGREEMENT d43593aexv99w1.htm EX-99.1 15298
  Complete submission text file 0000950134-07-003566.txt   130511
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 07631719
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

IRS No.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G